Depression in Multiple Sclerosis

Depression in Multiple Sclerosis

Up next

Understanding Physical Exam Findings Associated With FND - Part 2

In part two of this four-part series, Casey Kozak discusses Hover's sign, the most well-known test for FND. Show transcript: Casey Kozak: Welcome back to Neurology Minute. My name is Casey Kozak with Rutgers, and today we're continuing our examination of functional neurological d ...  Show more

Understanding Physical Exam Findings Associated With FND - Part 1

In part one of this four-part series, Casey Kozak breaks down tremors observed during the physical examination of FND. Show transcript: Casey Kozak: Welcome back to Neurology Minute. This is Casey Kozak with Rutgers, and today we'll be discussing a very important and evolving top ...  Show more

Recommended Episodes

Multiple Sclerosis and Family Planning
Neurology® Podcast

Dr. Shuvro Roy talks with Dr. Riley Bove about managing patients with multiple sclerosis as they navigate family planning and pregnancy. Read the related article in Neurology: Clinical Practice. Disclosures can be found at Neurology.org. 

MS in the Black Community
The ECTRIMS Podcast

With the growing push towards taking a more personalised approach to the treatment and management of multiple sclerosis, it is important to understand the unique issues – both socially and clinically – that may arise among people of different ethnicities. In this episode, Natalie ...  Show more

Winning Strategies in Multiple Sclerosis Treatment: Don't Underestimate the Disease
MS Living Well: Key Info from Multiple Sclerosis Experts

Treatment approaches to multiple sclerosis continue to change. Over the past quarter of a century, MS went from an untreatable disease to a disease responsive to a broad array of oral, intravenous and self-injected medications. Greater long-term disease control is now possible fo ...  Show more

Multiple Sclerosis, Rituximab, Hypogammaglobulinemia and Risk of Infections
Neurology® Podcast

Dr. Shuvro Roy talks with Dr. Annette Langer-Gould about the effective dose of rituximab and other B-cell depleting therapies in patients with multiple sclerosis, as well as important comorbidities to prevent infection risks. Read the related article in Neurology: Neuroimmunology ...  Show more